Food News and Research

RSS

Indevus announces agreement with Pliva for overactive bladder treatment drug

Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.

10 Apr 2004

Australian symposium on stroke and head injury

A condition which leaves some stroke and head injury victims unable to see half their world will be the subject of a one-day symposium being hosted by Southern Cross University (SCU) this week.

10 Apr 2004

Low carb diets should be avoided by growing children and adolescents

Even if you're not eating "low-carb," it's a good bet you at least know several people who are. Many people have found this the way to lose and maintain weight, while others argue that although you may see results, it could ultimately cause health problems such as heart disease. Most pediatricians would agree that a low-carb diet is not one a growing child should embrace.

9 Apr 2004

Roche announces new dosing strategy

Roche has announced results from a study demonstrating that the new boosted dosing regimen for its protease inhibitor Invirase(R) (saquinavir 1000 mg with ritonavir 100 mg twice-daily) has no significant interactions when it is co-administered with tenofovir disoproxil fumarate (300 mg once-daily).

9 Apr 2004

New microgel could potentially recover any enzyme and save manufacturers considerable money

Carnegie Mellon University scientists have employed biological molecules to create a microgel that could recover costly enzymes for repeated use in catalyzing commercially important reactions. The microgel could potentially recover any enzyme and theoretically save manufacturers considerable money.

8 Apr 2004

New AMA guide on treating foodborne illness

In partnership with a national nursing organization and several federal agencies, the AMA released an educational guide on April 7 about how health care professionals should identify and treat foodborne illnesses. "Diagnosis and Management of Foodborne Illnesses: A Primer for Physicians and Other Health Care Professionals" contains charts, scenarios and a continuing medical education section. It is free to health care professionals.

8 Apr 2004

Results of Creutzfeldt-Jakob disease research in people who received human growth hormone from cadavers

The largest study of its kind, designed to track the development of Creutzfeldt-Jakob disease in people who received human growth hormone from cadavers, has found that the vast majority of those who received the hormone did not contract the fatal condition. However, some recipients (26 out of approximately 7,700) did develop the disease.

7 Apr 2004

International obesity experts form a team to review and evaluate obesity

In an effort to help medical professionals, policy-makers, researchers, the news media and the general public evaluate the quality and usefulness of obesity research, a group of international obesity experts has formed a team that will review and evaluate published research papers in the field of obesity.

7 Apr 2004

Effects of lead in petrol are well-known however a recent additive to petrol manganese may be just as toxic

The disastrous environmental and health effects of lead in petrol are well-known, and western countries have been phasing it out for many years now. However, a recent additive to petrol - manganese - may be just as toxic. A Macquarie University study aims to find out.

7 Apr 2004

Analysis of Bacterial Genomes Begins to Unravel Complex Story of Metabolic Evolution

In a paper published in the current issue of the journal Molecular Biology and Evolution , Arizona State University biochemists Jason Raymond, Christopher Staples and Robert Blankenship and Rice University's Janet Siefert do an analysis of the genomes of a large group of bacteria and archaea, comparing in particular similar genes that produce the protein nitrogenase.

7 Apr 2004

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis

Centocor, Inc., announced today that the U.S. Food and Drug Administration (FDA) has accepted its filing of a supplemental Biologics License Application (sBLA) for REMICADE® (infliximab) as first-line therapy, in combination with methotrexate, for the treatment of early rheumatoid arthritis (RA) patients with moderately-to-severely active disease. REMICADE®, in combination with methotrexate, is currently indicated in the U.S. for reducing signs and symptoms, inhibiting the progression of structural damage and improving physical function in patients with moderately-to-severely active RA who have had an inadequate response to methotrexate alone.

6 Apr 2004

The Food and Drug Administration issues warning on antidepressants

The Food and Drug Administration (FDA) is issuing a warning about the possibility of worsening depression or suicidal thought in people, particularly children, who take any of 10 popular antidepressants, especially at the beginning of treatment or when the dosage is changed.

6 Apr 2004

New York - Due to changing blood donor criteria, donor deferral rates have been increasing since 1999

Due to changing blood donor criteria, donor deferral rates have been increasing since 1999 with trend lines predicting additional deferral increases. This predicament has created a critical demand for new people to step forward to donate to ensure there is an adequate supply of blood for hospital patients in New York and New Jersey who require life-saving transfusions, reports New York Blood Center (NYBC) officials.

6 Apr 2004

Consumer trust in food is high in the United Kingdom, Denmark, and Norway, but low in Italy and Portugal

Consumer trust in food is high in the United Kingdom, Denmark, and Norway, but low in Italy and Portugal and relatively low in Germany. Research also shows that consumers in these countries are most sceptical about meat products, fast-food outlets and food processors.

5 Apr 2004

Functional food, beyond providing a purely nutritional value, may promote health or reduce the risk of disease

Functional food, beyond providing a purely nutritional value, may promote health or reduce the risk of disease. An example is food meant to lower the cholesterol level. During the past few years, the potential benefits posed by functional foods have led to an increased interest by producers and consumers as well as a broader range of such products on the market worldwide.

5 Apr 2004

Cordis Cardiology receives warning from the U.S. Food and Drug Administration

Cordis Cardiology, a division of Cordis Corporation, a Johnson & Johnson Company, reported today that it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding FDA's observations concerning the Good Manufacturing Practice (GMP) regulations.

5 Apr 2004

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

ProMetic Life Sciences Inc. has announced today that its joint venture with the American Red Cross, Pathogen Removal and Diagnostic Technology Inc. ("PRDT"), has confirmed that treatment of TSE spiked red blood cell concentrate with its Prion Reduction Device results in a significant decrease in associated infectivity.

5 Apr 2004

Upcoming symposium to examine mercury exposure

The AMA is co-sponsoring a symposium for CME credit this month in Tampa, Fla., on the medical and public health aspects of mercury exposure. "Mercury: Medical and Public Health Issues" will be held from April 28-30 at the Tampa Marriott Waterside Hotel and Marina.

5 Apr 2004

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad’ cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU’s mutual recognition procedure.

4 Apr 2004

Dangers of ‘hidden ingredients’ in breakfast cereals

The Stroke Association warned today against the hidden dangers from the high levels of salt, sugar and fat found in many popular breakfast cereals enjoyed by both children and adults.

4 Apr 2004

Food News and Research

Indevus announces agreement with Pliva for overactive bladder treatment drug

Australian symposium on stroke and head injury

Low carb diets should be avoided by growing children and adolescents

Roche announces new dosing strategy

New microgel could potentially recover any enzyme and save manufacturers considerable money

New AMA guide on treating foodborne illness

Results of Creutzfeldt-Jakob disease research in people who received human growth hormone from cadavers

International obesity experts form a team to review and evaluate obesity

Effects of lead in petrol are well-known however a recent additive to petrol manganese may be just as toxic

Analysis of Bacterial Genomes Begins to Unravel Complex Story of Metabolic Evolution

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis

The Food and Drug Administration issues warning on antidepressants

New York - Due to changing blood donor criteria, donor deferral rates have been increasing since 1999

Consumer trust in food is high in the United Kingdom, Denmark, and Norway, but low in Italy and Portugal

Functional food, beyond providing a purely nutritional value, may promote health or reduce the risk of disease

Cordis Cardiology receives warning from the U.S. Food and Drug Administration

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

Upcoming symposium to examine mercury exposure

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

Dangers of ‘hidden ingredients’ in breakfast cereals

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News